Oxford Index Search Results

You are looking at 41-60 of 1,036 items for:

virus x Medical Oncology x clear all

Effects of Intravenously Administered Recombinant Vesicular Stomatitis Virus (VSVΔM51) on Multifocal and Invasive Gliomas

XueQing Lun, Donna L. Senger, Tommy Alain, Andra Oprea, Kelley Parato, Dave Stojdl, Brian Lichty, Anthony Power, Randal N. Johnston, Mark Hamilton, Ian Parney, John C. Bell and Peter A. Forsyth.

in JNCI: Journal of the National Cancer Institute

November 2006; p ublished online November 2006 .

Journal Article. Subjects: Medical Oncology. 9457 words.

Background: An ideal virus for the treatment of cancer should have effective delivery into multiple sites within the tumor, evade immune responses, produce rapid viral...

Go to »  full text: open access

Seneca Valley Virus, a Systemically Deliverable Oncolytic Picornavirus, and the Treatment of Neuroendocrine Cancers

P. Seshidhar Reddy, Kevin D. Burroughs, Laura M. Hales, Shanthi Ganesh, Brian H. Jones, Neeraja Idamakanti, Carl Hay, Shawn S. Li, Kristine L. Skele, Ann-Jeanette Vasko, Jingping Yang, D. Neil Watkins, Charles M. Rudin and Paul L. Hallenbeck.

in JNCI: Journal of the National Cancer Institute

November 2007; p ublished online November 2007 .

Journal Article. Subjects: Medical Oncology. 7209 words.

Background

Numerous clinical trials have demonstrated that oncolytic viruses can elicit antitumor responses when they are administered directly into...

Go to »  full text: open access   » abstract

Cell and Molecular Biology of Simian Virus 40: Implications for Human Infections and Disease

Janet S. Butel and John A. Lednicky.

in JNCI: Journal of the National Cancer Institute

January 1999; p ublished online January 1999 .

Journal Article. Subjects: Medical Oncology. 14214 words.

Simian virus 40 (SV40), a polyomavirus of rhesus macaque origin, was discovered in 1960 as a contaminant of polio vaccines that were distributed to millions of people from 1955 through...

Tumor-Specific Gene Delivery Using Recombinant Vaccinia Virus in a Rabbit Model of Liver Metastases

Michael F. X. Gnant, Linda A. Noll, Kari R. Irvine, Markus Puhlmann, Richard E. Terrill, H. Richard Alexander and David L. Bartlett.

in JNCI: Journal of the National Cancer Institute

October 1999; p ublished online October 1999 .

Journal Article. Subjects: Medical Oncology. 6160 words.

BACKGROUND: Several approaches to gene therapy for cancer have yielded promising results in rodent models. The translation of these results to the clinical realm has been delayed by the...

Characterization of recombinant influenza B viruses with key neuraminidase inhibitor resistance mutations

David Jackson, Wendy Barclay and Thomas Zürcher.

in Journal of Antimicrobial Chemotherapy

February 2005; p ublished online February 2005 .

Journal Article. Subjects: Medical Oncology; Critical Care. 6338 words.

Objectives and methods: An influenza B virus plasmid-based rescue system was used to introduce site-specific mutations, previously observed in neuraminidase (NA)...

Go to »  abstract

Reactivation of Hepatitis B Virus Infection in Pancreatic Cancer: a Case Report

Berna Öksüzoğlu, Saadettin Kiliçkap and Şuayib Yalcin.

in Japanese Journal of Clinical Oncology

December 2002; p ublished online December 2002 .

Journal Article. Subjects: Medical Oncology. 1470 words.

Impairment of liver function can be seen in cancer patients for a variety of reasons including metastasis, biliary obstruction, toxicity of chemotherapy or other concomittant drugs, can be...

Go to »  abstract

Hepatitis G Virus Infection in Patients with Hepatocellular Carcinoma in Recife, Brazil

Gustavo Carneiro Leão-Filho, Edmundo P. A. Lopes, Álvaro Antônio B. Ferraz, Izolda Moura, J. Ricardo Pernambuco, Cynthia Reis, Antônio Eduardo B. Silva and Maria Lucia G. Ferraz.

in Japanese Journal of Clinical Oncology

August 2007; p ublished online August 2007 .

Journal Article. Subjects: Medical Oncology. 3323 words.

The evidence of a higher incidence of hepatitis G virus (HGV) infection among patients with hepatocellular carcinoma (HCC) and the relatively high prevalence of patients with primary liver...

Go to »  abstract

Strain-specific antiviral activity of iminosugars against human influenza A viruses

S. Hussain, J. L. Miller, D. J. Harvey, Y. Gu, P. B. Rosenthal, N. Zitzmann and J. W. McCauley.

in Journal of Antimicrobial Chemotherapy

January 2015; p ublished online September 2014 .

Journal Article. Subjects: Medical Oncology; Critical Care. 10920 words.

Objectives

Drugs that target host cell processes can be employed to complement drugs that specifically target viruses, and iminosugar compounds that inhibit...

Go to »  full text: open access

Inhibition of Murine Prostate Tumor Growth and Activation of Immunoregulatory Cells With Recombinant Canarypox Viruses

Thomas S. Griffith, Mutsushi Kawakita, Jun Tian, Julie Ritchey, James Tartaglia, Inder Sehgal, Timothy C. Thompson, Weicheng Zhao and Timothy L. Ratliff.

in JNCI: Journal of the National Cancer Institute

July 2001; p ublished online July 2001 .

Journal Article. Subjects: Medical Oncology. 8342 words.

Background: Immunization with modified tumor cells carrying recombinant immunomodulatory genes is being explored as cancer immunotherapy. In this study, we examine whether...

Retrospective and prospective studies of hepatitis B virus reactivation in malignant lymphoma with occult HBV carrier

N. Fukushima, T. Mizuta, M. Tanaka, M. Yokoo, M. Ide, T. Hisatomi, N. Kuwahara, R. Tomimasu, N. Tsuneyoshi, N. Funai and E. Sueoka.

in Annals of Oncology

December 2009; p ublished online June 2009 .

Journal Article. Subjects: Medical Oncology. 2830 words.

Background: In surface antigen of hepatitis B virus (HBsAg)-positive carrier for anticancer treatment of malignant lymphoma, it is well recognized that reactivation of...

Go to »  abstract

The role of Epstein—Barr virus in the pathogenesis of Hodgkin's disease

G. Niedobitek.

in Annals of Oncology

January 1996 .

Journal Article. Subjects: Medical Oncology. 0 words.

Summary

Hodgkin's disease represents a phenotypically and genotypically heterogeneous lymphoma of CD30-positive tumour cells. Infection of the putative...

Go to »  abstract

A Population-Based Study of Hepatitis D Virus as Potential Risk Factor for Hepatocellular Carcinoma

Jianguang Ji, Kristina Sundquist and Jan Sundquist.

in JNCI: Journal of the National Cancer Institute

May 2012; p ublished online March 2012 .

Journal Article. Subjects: Medical Oncology. 1915 words.

Hepatitis D virus (HDV) is dependent on the presence of hepatitis B virus (HBV) for transmission and replication because of its inability to produce its own coat. It remains unclear whether...

Go to »  abstract

A zanamivir dimer with prophylactic and enhanced therapeutic activity against influenza viruses

E. Bart Tarbet, Stephanie Hamilton, Almut H. Vollmer, Angela Luttick, Wy Ching Ng, Melinda Pryor, Brett L. Hurst, Simon Crawford, Donald F. Smee and Simon P. Tucker.

in Journal of Antimicrobial Chemotherapy

August 2014; p ublished online April 2014 .

Journal Article. Subjects: Medical Oncology; Critical Care. 7105 words.

Objectives

Emerging drug resistance to antiviral therapies is an increasing challenge for the treatment of influenza virus infections. One new antiviral...

Phenotypic and genotypic characterization of influenza virus mutants selected with the sialidase fusion protein DAS181

Gallen B. Triana-Baltzer, Rebecca L. Sanders, Maria Hedlund, Kellie A. Jensen, Laura M. Aschenbrenner, Jeffrey L. Larson and Fang Fang.

in Journal of Antimicrobial Chemotherapy

January 2011; p ublished online November 2010 .

Journal Article. Subjects: Medical Oncology; Critical Care. 7713 words.

Background

Influenza viruses (IFVs) frequently achieve resistance to antiviral drugs, necessitating the development of compounds with novel mechanisms of...

Go to »  abstract

In vitro inactivation of Chlamydia trachomatis and of a panel of DNA (HSV-2, CMV, adenovirus, BK virus) and RNA (RSV, enterovirus) viruses by the spermicide benzalkonium chloride

Laurent Bélec, Carol Tevi-Benissan, Anne Bianchi, Sylvie Cotigny, Maria Beumont-Mauviel, Ali Si-Mohamed and Jean-Elie Malkin.

in Journal of Antimicrobial Chemotherapy

November 2000; p ublished online November 2000 .

Journal Article. Subjects: Medical Oncology; Critical Care. 5092 words.

Kinetics of inactivation by the detergent spermicide benzalkonium chloride (BZK) of Chlamydia trachomatis and of a panel of DNA viruses [herpes simplex virus hominis type 2 (HSV-2),...

Go to »  abstract

Effect of Canarypox Virus (ALVAC)-Mediated Cytokine Expression on Murine Prostate Tumor Growth

Mutsushi Kawakita, Ganesh S. Rao, Julie K. Ritchey, David K. Ornstein, M'Liss A. Hudson, Taz J. Harmon, Timothy L. Ratliff, Peter A. Humphrey, James Tartaglia and Enzo Paoletti.

in JNCI: Journal of the National Cancer Institute

March 1997; p ublished online March 1997 .

Journal Article. Subjects: Medical Oncology. 6519 words.

Background: Canarypox virus, ALVAC, does not replicate in infected mammalian cells and has potential as a vector for gene therapy in the treatment of cancer. Purpose: Recombina...

Association Between Simian Virus 40 DNA and Lymphoma in the United Kingdom

Jane MacKenzie, Katherine S. Wilson, Jacqueline Perry, Alice Gallagher and Ruth F. Jarrett.

in JNCI: Journal of the National Cancer Institute

July 2003; p ublished online July 2003 .

Journal Article. Subjects: Medical Oncology. 2379 words.

Recent studies have reported the presence of simian virus 40 (SV40) DNA sequences in approximately 40% of tumor samples from non-Hodgkin’s lymphoma (NHL) patients from the United States. We...

Lack of Serologic Evidence for Prevalent Simian Virus 40 Infection in Humans

Joseph J. Carter, Margaret M. Madeleine, Greg C. Wipf, Robert L. Garcea, Pam A. Pipkin, Philip D. Minor and Denise A. Galloway.

in JNCI: Journal of the National Cancer Institute

October 2003; p ublished online October 2003 .

Journal Article. Subjects: Medical Oncology. 8063 words.

Background: Propagation of poliovirus in monkey kidney cells led to the inadvertent contamination of poliovirus vaccines with simian virus 40 (SV40) between 1955 and 1963....

Stem Cells Loaded With Multimechanistic Oncolytic Herpes Simplex Virus Variants for Brain Tumor Therapy

Matthias Duebgen, Jordi Martinez-Quintanilla, Kaoru Tamura, Shawn Hingtgen, Navid Redjal, Hiroaki Wakimoto and Khalid Shah.

in JNCI: Journal of the National Cancer Institute

P ublished online May 2014 .

Journal Article. Subjects: Medical Oncology. 6039 words.

Background

The current treatment regimen for malignant glioblastoma multiforme (GBM) is tumor resection followed by chemotherapy and radiation therapy....

In vitro passaging of a pandemic H1N1/09 virus selects for viruses with neuraminidase mutations conferring high-level resistance to oseltamivir and peramivir, but not to zanamivir

Jennifer L. McKimm-Breschkin, Christina Rootes, Peter G. Mohr, Susan Barrett and Victor A. Streltsov.

in Journal of Antimicrobial Chemotherapy

August 2012; p ublished online May 2012 .

Journal Article. Subjects: Medical Oncology; Critical Care. 7159 words.

Objectives

Pandemic H1N1/09 viruses with the neuraminidase H274Y mutation have emerged in untreated patients or following oseltamivir therapy or prophylaxis....

Go to »  abstract